Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Therapy for patients with ST-elevation myocardial infarction (STEMI) has been a controversial topic since the introduction of thrombolytic agents in the 1980s. The use of morphine, fentanyl and lidocaine has increased substantially during this period. However, there is still limited evidence on their advantages and limitations. In this review, the clinical application, as well as future considerations of morphine, fentanyl and lidocaine in patients with ST segment elevation myocardial infarction were discussed.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073464 | PMC |
| http://dx.doi.org/10.3389/fmed.2023.1148581 | DOI Listing |
Publication Analysis
Top Keywords
myocardial infarction
8
morphine fentanyl
8
fentanyl lidocaine
8
analgesic drug
4
drug patients
4
patients stemi
4
stemi current
4
current perspectives
4
perspectives challenges
4
challenges therapy
4